CAS 26095-59-0
:Otilonium bromide
Description:
Otilonium bromide is a synthetic quaternary ammonium compound primarily used as an antispasmodic agent. It is characterized by its ability to relax smooth muscle, making it effective in treating gastrointestinal disorders, particularly those involving spasms, such as irritable bowel syndrome. The compound functions by blocking calcium channels, which helps to alleviate muscle contractions. Otilonium bromide is typically administered in oral form and is known for its relatively low side effect profile compared to other antispasmodics. Its solubility in water is moderate, and it is often formulated with other excipients to enhance its stability and bioavailability. The substance is generally well-tolerated, but like all medications, it may cause adverse effects in some individuals, including dry mouth or dizziness. As with any pharmaceutical, its use should be guided by a healthcare professional, considering the patient's specific medical history and condition. Overall, Otilonium bromide represents a valuable option in the management of gastrointestinal motility disorders.
Formula:C29H43N2O4·Br
InChI:InChI=1S/C29H42N2O4.BrH/c1-5-8-9-10-11-14-22-34-27-16-13-12-15-26(27)28(32)30-25-19-17-24(18-20-25)29(33)35-23-21-31(4,6-2)7-3;/h12-13,15-20H,5-11,14,21-23H2,1-4H3;1H
InChI key:InChIKey=VWZPIJGXYWHBOW-UHFFFAOYSA-N
SMILES:O(CCCCCCCC)C1=C(C(NC2=CC=C(C(OCC[N+](CC)(CC)C)=O)C=C2)=O)C=CC=C1.[Br-]
Synonyms:- 247-457-4
- Ammonium, diethyl(2-hydroxyethyl)methyl-, bromide, p-[o-(octyloxy)benzamido]benzoate
- Benzoic acid, p-[o-(octyloxy)benzamido]-, ester with diethyl(2-hydroxyethyl)methylammonium bromide
- Ethanaminium, N,N-diethyl-N-methyl-2-[[4-[[2-(octyloxy)benzoyl]amino]benzoyl]oxy]-, bromide
- Ethanaminium, N,N-diethyl-N-methyl-2-[[4-[[2-(octyloxy)benzoyl]amino]benzoyl]oxy]-, bromide (1:1)
- N,N-Diethyl-N-methyl-2-[(4-{[2-(octyloxy)benzoyl]amino}benzoyl)oxy]ethanaminium bromide
- N,N-diethyl-2-[(4-{[2-(heptyloxy)benzoyl]amino}benzoyl)oxy]-N-methylethanaminium bromide
- Octylonium bromide
- Sp 63
- Spasmomen
- Otilonium bromide
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Found 11 products.
Ethanaminium, N,N-diethyl-N-methyl-2-[[4-[[2-(octyloxy)benzoyl]amino]benzoyl]oxy]-, bromide (1:1)
CAS:Formula:C29H43BrN2O4Purity:98%Color and Shape:SolidMolecular weight:563.5667Otilonium bromide
CAS:Otilonium bromide (SP63) , an antimuscarinic, is utilized as a spasmolytic agent.Formula:C29H43BrN2O4Purity:98.88% - 99.78%Color and Shape:White PowerMolecular weight:563.57Otilonium-d4 Bromide
CAS:Formula:C29H39D4N2O4·BrColor and Shape:White To Off-White SolidMolecular weight:487.70 79.90N,N-Diethyl-N-Methyl-2-((4-(2-(Octyloxy)Benzamido)Benzoyl)Oxy)Ethanaminium Bromide
CAS:N,N-Diethyl-N-Methyl-2-((4-(2-(Octyloxy)Benzamido)Benzoyl)Oxy)Ethanaminium BromidePurity:98%Molecular weight:563.57g/molOctylonium bromide
CAS:Formula:C29H43BrN2O4Purity:≥ 98.0%Color and Shape:White to off-white or beige powderMolecular weight:563.57Otilonium Bromide
CAS:Formula:C29H43N2O4·BrColor and Shape:White To Off-White SolidMolecular weight:483.67 79.90Octylonium-d3 Bromide
CAS:Controlled Product<p>Applications Labelled Octylonium Bromide (O293250). Octylonium bromide is an antimuscarinic. Octylonium bromide is a platelet-activating factor antagonist as analgesic, anti-inflammatory, uterine contraction inhibiting, and anti-tumor agent. Octylonium bromide is used as an antispasmodic.<br>References Manzini, S., et al.: Drugs Exp. Clin. Res., 14, 265 (1988), Emonds-Alt, X., et al.: Eur. J. Pharmacol., 250, 403 (1993), Sutton, J., et al.: Eur. J. Clin. Pharmacol., 52, 365 (1997), Catalioto, R., et al.: Br. J. Pharmacol., 123, 81 (1998),<br></p>Formula:C29H40D3BrN2O4Color and Shape:NeatMolecular weight:566.59Octylonium bromide
CAS:<p>Octylonium bromide is an otilonium-based compound that has been shown to be effective in the treatment of bowel disease. Octylonium bromide inhibits inflammatory and non-inflammatory bowel disease by inhibiting the production of proinflammatory cytokines, such as tumor necrosis factor alpha (TNFα), IL-1β, IL-6, and IL-8. Octylonium bromide also controls the signal pathways involved in the release of these cytokines. Octylonium bromide has been shown to have a statistically significant effect on diabetic neuropathy and urinary incontinence. This drug is absorbed through the stomach and small intestine into the blood stream. It then enters cells where it binds to specific sites on receptors, such as the neurokinin-1 receptor (NK1R). The NK1R is found in many different tissues throughout the body, including in smooth muscle cells of the bladder wall (detrusor muscle) and sensory neurons in peripheral</p>Formula:C29H43BrN2O4Purity:Min. 95%Color and Shape:White PowderMolecular weight:563.57 g/mol







